返回成功案例
私募基金 | 医疗健康

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Agar is a global leader in the distribution and manufacture of electron microscopy consumables. The business was created as the result of an MBO carve out backed by Foresight Group in 2016. Since then, the firm has more than doubled in size under the stewardship of Darren Likely and the Agar management team. Agar has a strong strategic fit with Calibre, providing many synergy benefits. It will enable Calibre to expand their customer base and open up new markets in high growth areas.

Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, with an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth, its global reach extends into over 100 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.

Oaklins Cavendish, based in the UK, acted as advisor to Agar Scientific in this transaction.

我们的服务
交易方
“We’re excited to be joining the Calibre Scientific family, who will enable us to further accelerate our long-term strategic growth objectives. The Oaklins Cavendish team has achieved a fantastic result for our shareholders. Their wealth of sector expertise, professionalism and unwavering dedication throughout the process were instrumental in achieving a successful completion.”

Darren Likely

CEO, Agar Scientific Ltd.

联系交易团队

Michael Jewell

合伙人
伦敦, 英国
Oaklins Cavendish

相关交易

Bayer AG has entered into a takeover agreement with Cara Care
医疗健康 | 科技、媒体及通讯

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

更多信息
Mark Climate Technology has acquired Heber GmbH
私募基金 | 工业机械与零部件 | 其他行业

Mark Climate Technology has acquired Heber GmbH

Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.

更多信息
Grupo Veta 2017 S.L. has been acquired by MSA Mizar
私募基金 | 商业与营运支持服务 | 金融服务 | 科技、媒体及通讯

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.

更多信息